Pharmaceutics and Preformulation: Salt Formation, pH-Solubility Profiles, and Dissolution Kinetics

Exam Preparation, Units, and Equation Sheet Guidelines

• Dedicated Equation Sheets and Scratch Paper:

  • An official equation sheet is provided during examinations that also serves as scratch paper.
  • Studying should be conducted using this specific sheet rather than searching through lecture notebooks, ensuring rapid familiarity with formula layouts.
  • Allowed and Prohibited Tools: Graphing calculators are strictly prohibited; standard scientific calculators are required.
  • Mechanical pencils and erasers are strongly recommended due to the extensive calculations required for pharmaceutics, preformulation, and drug stability topics.

• Strict Unit Uniformity in Equations:

  • All physical units within any pharmaceutical equation must match precisely prior to computation.
  • Molar concentrations ($mol\,dm^{-3}$) must never be mixed directly with percentage expressions, such as percent weight-by-weight ($\%\,w/w$) or percent weight-by-volume ($\%\,w/v$).
  • Standard conversion of percent weight-by-volume ($\%\,w/v$) to molarity:
  • A concentration of $1\,\%\,w/v$ equals $1\,g$ of solute per $100\,cm^3$ of solution.
  • Expressed per liter ($1000\,cm^3$), this corresponds to $10\,g\,dm^{-3}$.
  • Molarity ($M$) is obtained by dividing the mass concentration in $g\,dm^{-3}$ by the solute's molecular weight ($MW$) in $g\,mol^{-1}$:       $M = \frac{\text{Concentration in } g\,dm^{-3}}{MW}$

• Rounding and Numerical Precision Standard:

  • When determining fraction ionized ($f_{\text{ionized}}$) or fraction unionized ($f_{\text{unionized}}$), values must be rounded precisely to the ten-thousandths place (four decimal places, e.g., $0.9825$).

Principles of Drug Solubility and Salt Formation

• Fundamental Purpose of Salt Formation:

  • Salt formation serves as a primary pharmaceutical strategy to enhance the aqueous solubility and dissolution rate of weak electrolytes that are poorly soluble or highly lipophilic.
  • Limitation: Drugs lacking ionizable functional groups (e.g., paclitaxel) cannot form salts; such molecules require alternative formulation strategies (e.g., specialized drug delivery systems, lipid formulations, or cosolvents) to enable dissolution and membrane transport.

• Core Chemical Requirement:

  • Formation of a pharmaceutical salt requires combining an ionizable weak electrolyte with an appropriate strong counterion.
  • A weak base drug must be paired with a strong acid.
  • A weak acid drug must be paired with a strong base.

• Common Strong Acid Counterions (Anions):

  • Hydrochloric acid ($HCl$) yields hydrochloride salts.
  • Sulfuric acid ($H_2SO_4$) yields sulfate salts ($SO_4^{2-}$).
  • Phosphoric acid ($H_3PO_4$) yields phosphate salts.
  • Acetic acid ($CH_3COOH$) yields acetate salts (relatively strong compared to weak electrolyte drug substances).

• Common Strong Base Counterions (Cations):

  • Sodium hydroxide ($NaOH$) yields sodium salts ($Na^+$); approximately $63\%$ of all commercial salt-form drugs are sodium salts.
  • Potassium hydroxide ($KOH$) yields potassium salts ($K^+$).
  • Calcium hydroxide ($Ca(OH)_2$) yields calcium salts ($Ca^{2+}$, e.g., atorvastatin calcium).
  • Aluminum hydroxide ($Al(OH)_3$) yields aluminum salts.

• Hierarchical Classification of Pharmaceutical Salts:

  • First-Class Salts:
  • Formed from counterions that are physiological, naturally occurring, and endogenous to the human body (e.g., sodium, potassium, calcium, magnesium, chloride, sulfate, phosphate).
  • Designated as GRAS (Generally Regarded As Safe) because they are ubiquitous in normal human physiology, presenting minimal inherent toxicity risks under normal physiological ranges.
  • Second-Class Salts:
  • Formed from counterions that are not naturally occurring in the human body but are commonly used in approved pharmaceutical products.
  • Possess thoroughly characterized, well-documented safety and toxicological profiles.
  • Prominent example: Mesylate (methanesulfonate) salts.
  • Third-Class Salts:
  • Formed from counterions that are neither naturally occurring nor commonly used in pharmaceutical manufacturing.
  • Reserved for specialized compounds where first- or second-class counterions fail to produce stable, crystalline, or soluble salts.
  • Require ongoing safety evaluations and rigorous post-marketing surveillance to monitor long-term toxicological outcomes.

• Route of Administration and Physiological pH Concerns:

  • Direct intravenous (IV) bolus injections bypass the dilution capacity of large-volume infusion bags (such as normal saline or dextrose infusions).
  • Blood physiological pH is tightly maintained at $7.4$.
  • Injecting a drug solution whose pH deviates substantially from $7.4$ poses a severe risk of localized drug precipitation inside the blood vessel, resulting in vascular irritation, phlebitis, and perivascular tissue necrosis.
  • Large-volume infusions with extreme pH imbalances can disturb systemic acid-base homeostasis, potentially leading to metabolic acidosis or alkalosis.

Stoichiometric Mechanisms of Salt Dissolution

• Organic Solvent Environment in Salt Synthesis:

  • Salt synthesis is typically executed within organic solvents rather than aqueous media.
  • Performing salt synthesis in water leads to continuous premature dissolution of the newly formed salt, preventing efficient crystallization and recovery.

• Weak Base Salt Dissolution Dynamics:

  • Salt Synthesis Reaction:     A free base ($B$) reacts with a strong acid ($HCl$) to produce the conjugate acid salt:     $B + HCl \rightarrow BH^+ + Cl^-$
  • Aqueous Dissolution and Hydrolysis Reaction:     When introduced into an aqueous environment, the salt dissociates, and the conjugate acid protonates water:     $BH^+ + H_2O \rightleftharpoons B + H_3O^+ + Cl^-$
  • Mechanistic Consequence on Microenvironmental pH:
  • The release of hydronium ions ($H_3O^+$) substantially lowers the pH in the diffusion layer surrounding the dissolving drug particles.
  • An acidic microenvironment forces the weak base ($B$) into its ionized conjugate acid form ($BH^+$).
  • Ionization markedly elevates the aqueous solubility of the weak base in the boundary layer, accelerating overall dissolution into the bulk medium.

• Weak Acid Salt Dissolution Dynamics:

  • Salt Synthesis Reaction:     An un-ionized weak acid ($HA$) reacts with a strong base ($NaOH$) to generate the conjugate base salt:     $HA + NaOH \rightarrow Na^+ + A^- + H_2O$
  • Aqueous Dissolution and Hydrolysis Reaction:     When dissolved in water, the conjugate base hydrolyzes water molecules:     $A^- + H_2O \rightleftharpoons HA + OH^-$
  • Mechanistic Consequence on Microenvironmental pH:
  • The release of hydroxide ions ($OH^-$) elevates the pH of the microenvironment.
  • An alkaline boundary layer drives the weak acid ($HA$) into its fully dissociated, ionized state ($A^-$).
  • Because ionized species exhibit significantly greater aqueous solubility, dissolution proceeds rapidly.

• Invariant Nature of Intrinsic Solubility ($S_o$):

  • Forming a salt modifies the dissolution rate and microenvironmental pH, but does not alter the thermodynamic intrinsic solubility ($S_o$) of the free base or free acid molecule itself.

Mathematical Formulations and Governing Equations

• pH of a Weak Base Salt Solution:

  • Determines the resulting pH when a salt of a weak base is dissolved in water at a given molar concentration:     $pH = \frac{1}{2}\left(pK_a - \log[BH^+]\right)$
  • $pK_a$ represents the acid dissociation constant of the conjugate acid.
  • $[BH^+]$ represents the molar concentration ($mol\,dm^{-3}$) of the weak base salt in solution.

• pH of a Weak Acid Salt Solution:

  • Determines the resulting pH when a salt of a weak acid is dissolved in water at a given molar concentration:     $pH = \frac{1}{2}\left(pK_w + pK_a + \log[A^-]\right)$
  • $pK_w = 14$ at $25\,^{\circ}\text{C}$.
  • $[A^-]$ represents the molar concentration ($mol\,dm^{-3}$) of the weak acid salt.

• Total Solubility ($S_T$) Relationships:

  • Total solubility is the sum of the intrinsic solubility ($S_o$, un-ionized drug) and the ionized drug solubility ($S_i$):     $S_T = S_o + S_i$
  • Weak Acid Total Solubility:     $S_T = S_o\left(1 + 10^{pH - pK_a}\right)$
  • Weak Base Total Solubility:     $S_T = S_o\left(1 + 10^{pK_a - pH}\right)$

• Precipitation pH ($pH_p$):

  • Defines the critical pH threshold at which an un-ionized drug exceeds its solubility limit and begins precipitating out of solution.
  • Weak Acid Precipitation pH:     $pH_p = pK_a + \log\left(\frac{S_T - S_o}{S_o}\right)$
  • Weak Base Precipitation pH:     $pH_p = pK_a - \log\left(\frac{S_T - S_o}{S_o}\right)$

• Fraction Ionized and Un-ionized Formulations:

  • Weak Base Equations:     $f_{\text{ionized}} = \frac{1}{1 + 10^{pH - pK_a}}$$f_{\text{unionized}} = 1 - f_{\text{ionized}}$
  • Weak Acid Equations:     $f_{\text{ionized}} = \frac{1}{1 + 10^{pK_a - pH}}$$f_{\text{unionized}} = 1 - f_{\text{ionized}}$

• Apparent Distribution Coefficient ($\log(D)$):

  • Quantifies the overall lipophilicity of an ionizable drug across aqueous and lipid phases at a specific environmental pH:     $\log(D) = f_{\text{unionized}} \times \log(P)$
  • $\log(P)$ represents the intrinsic partition coefficient of the purely un-ionized drug species.

• Noyes-Whitney Dissolution Rate Equation:

  • Governs the rate of solid-state drug dissolution into liquid media:     $\frac{dM}{dt} = \frac{D \times A}{h}(C_s - C_b)$
  • $\frac{dM}{dt}$ represents the rate of dissolution (mass dissolved per unit time).
  • $D$ is the diffusion coefficient of the solute.
  • $A$ is the surface area of the dissolving drug particles exposed to the solvent.
  • $h$ is the thickness of the stagnant hydrodynamic diffusion layer.
  • $C_s$ is the saturation solubility of the drug in the stagnant boundary diffusion layer.
  • $C_b$ is the concentration of the drug in the bulk solution at time $t$.

pH-Solubility Profiles and Case Studies

• Morphological Identification of pH-Solubility Curves:

  • Weak Acid Profile (S-shaped curve):
  • At low pH values below the $pK_a$, the curve flattens into a lower plateau corresponding to the un-ionized intrinsic solubility ($S_o$).
  • As pH increases, ionization increases, producing an S-shaped rise toward high total solubility.
  • Weak Base Profile (Z-shaped curve):
  • At low pH values below the $pK_a$, the curve maintains an elevated plateau corresponding to the maximum solubility of the ionized salt form ($S_T$).
  • As pH rises into the basic range, solubility drops sharply, transitioning into a Z-shaped downward curve that terminates at the low intrinsic solubility plateau ($S_o$).
  • Plateau Interpretations on Empirical Curves:
  • Upper Horizontal Plateau: Represents the maximum solubility of the salt form ($S_T$).
  • Lower Horizontal Baseline: Represents the intrinsic solubility of the un-ionized free species ($S_o$).

• Case Study: Weak Acid Ionization and Intrinsic Solubility

  • Parameter Conditions: A weak acid with a $pK_a = 2.7$ is maintained in a solution at $pH = 8.0$, with a total solubility $S_T = 0.174\,mol\,dm^{-3}$.
  • Degree of Ionization:     $\Delta pH = pH - pK_a = 8.0 - 2.7 = 5.3$     Because the solution pH exceeds the $pK_a$ by more than two units ($5.3 > 2.0$), the drug is virtually $100\%$ ionized.
  • Determination of Un-ionized Species Concentration ($S_o$):
  • Un-ionized intrinsic solubility is extremely minute: $S_o \approx 1 \times 10^{-6}\,mol\,dm^{-3}$ (effectively approaching zero).
  • Determination of Ionized Species Solubility ($S_i$):     $S_i = S_T - S_o = 0.174 - (1 \times 10^{-6}) \approx 0.174\,mol\,dm^{-3}$

• Case Study: Ergotamine Tartrate Salt Solution

  • Parameter Conditions: Ergotamine tartrate is a weak base salt prepared at a concentration of $0.2\,mol\,dm^{-3}$, with a conjugate acid $pK_a = 6.25$.
  • Computational Steps for Solution pH:
  1. Identify the weak base salt equation:        $pH = \frac{1}{2}\left(pK_a - \log[BH^+]\right)$
  2. Evaluate the logarithmic concentration term:        $\log(0.2) = -0.699$
  3. Subtract the negative logarithm from the $pK_a$:        $pK_a - \log[BH^+] = 6.25 - (-0.699) = 6.25 + 0.699 = 6.949$
  4. Divide by two to obtain final solution pH:        $pH = \frac{6.949}{2} \approx 3.47$

• Case Study: Oxycodone Hydrochloride ($C_{18}H_{21}NO_4 \cdot HCl$)

  • Physical Properties and Molecular Weight:
  • Molecular Weight ($MW$) = $351.80\,g\,mol^{-1}$.
  • Class: Opioid analgesic, weak base formulated as a hydrochloride salt (First-Class salt due to endogenous chloride counterion).
  • Descriptive Solubility Classification in Aqueous Media:
  • Prescribing data states an aqueous solubility of $1\,g$ per $6\,cm^3$ of water (compared to $1\,g$ per $67\,cm^3$ in ethanol).
  • Converting to concentration in $mg\,cm^{-3}$:       $\frac{1000\,mg}{6\,cm^3} = 166.7\,mg\,cm^{-3} \approx 167\,mg\,cm^{-3}$
  • Pharmacopeial descriptive term: "Freely soluble" (defined as $100$ to $1000\,mg\,cm^{-3}$, corresponding to $1$ to $10$ parts solvent per $1$ part solute).
  • Calculation of pH for a $140\,mg\,cm^{-3}$ Oxycodone Hydrochloride Solution:
  1. Convert mass concentration to molarity ($M$):        $\frac{140\,mg}{1\,cm^3} = \frac{140\,g}{1000\,cm^3} = 140\,g\,dm^{-3}$$M = \frac{140\,g\,dm^{-3}}{351.80\,g\,mol^{-1}} = 0.398\,mol\,dm^{-3}$
  2. Utilize the weak base salt equation with $pK_a = 8.75$:        $pH = \frac{1}{2}\left(8.75 - \log(0.398)\right)$
  3. Evaluate logarithmic term:        $\log(0.398) \approx -0.400$
  4. Compute numerator and divide by two:        $pH = \frac{1}{2}\left(8.75 - (-0.400)\right) = \frac{1}{2}(8.75 + 0.400) = \frac{9.15}{2} = 4.58$
  • Total Solubility Calculation at $pH = 7.0$:
  • Intrinsic solubility from baseline: $S_o = 0.00127\,mol\,dm^{-3}$; $pK_a = 8.75$.
  • Applying the weak base formula:       $S_T = S_o\left(1 + 10^{pK_a - pH}\right)$$pK_a - pH = 8.75 - 7.00 = 1.75$$10^{1.75} \approx 56.23$$S_T = 0.00127 \times (1 + 56.23) = 0.00127 \times 57.23 \approx 0.0727\,mol\,dm^{-3}$
  • Determination of Precipitation pH ($pH_p$):
  • Given the upper plateau maximum salt solubility $S_T = 1.15\,mol\,dm^{-3}$ and intrinsic solubility $S_o = 0.00126\,mol\,dm^{-3}$:       $\frac{S_T - S_o}{S_o} = \frac{1.15 - 0.00126}{0.00126} = \frac{1.14874}{0.00126} \approx 911.70$$\log(911.70) \approx 2.96$
  • Solving the rearranged precipitation equation:       $pK_a - pH_p = 2.96$$pH_p = 8.75 - 2.96 = 5.79$
  • Oxycodone will begin precipitating out of solution if the pH rises above $5.79$.
  • Apparent Distribution Coefficient ($\log(D)$) at $pH = 7.0$:
  • Given $\log(P) = 0.70$ and $pK_a = 8.75$:
  1. Fraction ionized:        $f_{\text{ionized}} = \frac{1}{1 + 10^{pH - pK_a}} = \frac{1}{1 + 10^{7.00 - 8.75}} = \frac{1}{1 + 10^{-1.75}} = \frac{1}{1 + 0.01778} = \frac{1}{1.01778} \approx 0.9825$
  2. Fraction un-ionized rounded to the nearest ten-thousandth:        $f_{\text{unionized}} = 1 - 0.9825 = 0.0175$        (Using the exact unrounded fraction $0.01747 \approx 0.0172$ depending on intermediate calculator precision):
  3. Calculate $\log(D)$:        $\log(D) = 0.0172 \times 0.70 \approx 0.0120$

Preformulation Parameters, BCS Classification, and Dissolution Kinetics

• Biopharmaceutics Classification System (BCS):

  • Class I Definition: High Solubility, High Permeability.

• Optimal Preformulation Criteria for Candidate Drug Molecules:

  • Aqueous Solubility Threshold:
  • Must be strictly greater than $10\,mg\,cm^{-3}$ ($> 10\,mg\,cm^{-3}$); the threshold condition is strictly "greater than," not "greater than or equal to."
  • Lipophilicity Range ($\log(P)$):
  • Optimal candidate values fall between $1$ and $3$ ($1 < \log(P) < 3$).
  • This range establishes an ideal balance between aqueous solubility (necessary for dissolution) and membrane permeability (necessary for passive systemic absorption).
  • Intrinsic Dissolution Rate (IDR):
  • Must be strictly greater than $1\,mg\,cm^{-2}\,min^{-1}$ ($> 1\,mg\,cm^{-2}\,min^{-1}$).
  • Solid-State Form Selection:
  • Utilization of amorphous forms increases dissolution and apparent solubility, but is not mandatory.
  • Stable crystalline or metastable polymorphs are frequently selected depending on solid-state stability requirements.

• Manipulation of Noyes-Whitney Variables in Formulations:

  • Impact of Trituration (Particle Size Reduction):
  • Mortar and pestle trituration reduces average particle size.
  • Decreasing particle size increases the effective surface area ($A$) available for contact with the solvent.
  • By the Noyes-Whitney equation, increasing $A$ directly accelerates the rate of drug dissolution (increases $\frac{dM}{dt}$.
  • Under normal micron ranges, trituration does not alter saturation solubility ($C_s$) or bulk concentration ($C_b$).
  • Impact of Salt Formulation vs. Free Base Formulation:
  • Formulating an active ingredient as a salt rather than as its free base dramatically increases the saturation solubility ($C_s$) within the microenvironmental diffusion boundary layer.
  • As $C_s$ increases, the concentration gradient $(C_s - C_b)$ steepens, directly increasing the overall dissolution rate (increases $\frac{dM}{dt}$.

• Two-Unit Rule Governing Total vs. Intrinsic Solubility:

  • Weak Acid Rule:
  • Total solubility ($S_T$) equals intrinsic solubility ($S_o$) at all pH values at least two units below the $pK_a$ ($pH \le pK_a - 2$), where ionization is suppressed ($< 1\%$ ionized).
  • The drug achieves complete ionization at pH values at least two units above the $pK_a$ ($pH \ge pK_a + 2$).
  • Weak Base Rule:
  • Total solubility ($S_T$) equals intrinsic solubility ($S_o$) at all pH values at least two units above the $pK_a$ ($pH \ge pK_a + 2$).
  • The drug achieves complete ionization at pH values at least two units below the $pK_a$ ($pH \le pK_a - 2$).

Questions & Discussion

• Weak Acid Equation Selection:

  • Query: Enrique was asked to identify the appropriate mathematical equation to calculate un-ionized intrinsic solubility ($S_o$) for a weak acid from the equation sheet.
  • Discussion: Enrique initially cited the logarithmic precipitation equation: $pH = pK_a + \log\left(\frac{S_T - S_o}{S_o}\right)$.
  • Resolution: While mathematically valid, using the precipitation formula introduces unnecessary algebraic rearrangement steps (including calculating antilogs manually). The direct total solubility expression $S_T = S_o\left(1 + 10^{pH - pK_a}\right)$ is preferred because $S_o$ is isolated cleanly, minimizing multi-step computational errors on multiple-choice examinations.

• Reason for Near-Zero Intrinsic Solubility in Camille's Problem:

  • Query: Camille identified that $S_o$ was $1 \times 10^{-6}\,mol\,dm^{-3}$ (essentially zero). The question was posed: Why is $S_o$ so low under these conditions?
  • Response: The solution is at $pH = 8.0$, which is alkaline relative to the weak acid's $pK_a$ of $2.7$. Because the pH exceeds the $pK_a$ by $5.3$ units (far exceeding the two-unit threshold), the molecule dissociates completely into its ionized conjugate base, leaving almost no un-ionized drug in solution.

• Endogenous Ion Fluctuations and Dietary Controls:

  • Discussion: Eliza raised the point that while first-class salt counterions (such as sodium) are naturally occurring in the body, elevated concentrations can still produce pathology.
  • Response: High systemic sodium levels exacerbate cardiovascular disease and hypertension, necessitating pharmacologic interventions (antihypertensive agents) and dietary modifications (e.g., the DASH diet—Dietary Approaches to Stop Hypertension). However, from a raw formulation perspective, endogenous counterions remain classified as first-class because human metabolic systems possess native machinery to clear and regulate them.

• Intravenous Injection Site Precipitation vs. Systemic Acidosis/Alkalosis:

  • Query: A student suggested that injecting a drug solution with a non-physiological pH could induce systemic acidosis or alkalosis.
  • Response: A standard parenteral injection volume is typically far too small to alter systemic blood buffering capacity or shift systemic blood biochemistry into acidosis or alkalosis. The primary danger of localized IV injection of extreme pH solutions is rapid drug precipitation at the vein wall due to buffering by blood ($pH = 7.4$), causing severe local endothelial damage, phlebitis, and tissue necrosis.

• Oxycodone Hydrochloride Descriptive Solubility Confusion:

  • Query: Mark suggested oxycodone hydrochloride was "slightly soluble" based on prescribing data.
  • Correction: Lizanne noted that the package insert lists $1\,g$ per $67\,cm^3$ for alcohol, but for aqueous media (water), it dissolves at $1\,g$ per $6\,cm^3$. Converting $1\,g / 6\,cm^3$ yields $166.7\,mg\,cm^{-3}$, which falls within the official range for "freely soluble" ($100$ to $1000\,mg\,cm^{-3}$).

• Negative Signs during Precipitation pH Calculations:

  • Query: A student asked how to manage negative values appearing during precipitation calculations when subtracting $pK_a$ from the logarithmic term.
  • Clarification: For a weak base, the governing relationship is $pK_a - pH = \log\left(\frac{S_T - S_o}{S_o}\right)$. Subtracting $pK_a$ from both sides leaves $-pH = \log\left(\frac{S_T - S_o}{S_o}\right) - pK_a$. Dividing both sides by $-1$ or transposing terms across the equals sign resolves the negative sign, yielding a positive physiological pH value.

• Distinguishing Fraction Ionized vs. Fraction Un-ionized on Formula Sheets:

  • Query: Students noted confusion because the equation sheet provides the formula for fraction ionized ($f_{\text{ionized}}$), but log D calculations require fraction un-ionized ($f_{\text{unionized}}$).
  • Clarification: The equation sheet intentionally provides $f_{\text{ionized}}$. Students must compute $f_{\text{ionized}}$ first and subtract it from unity ($f_{\text{unionized}} = 1 - f_{\text{ionized}}$) before multiplying by $\log(P)$.

• Classroom Electronic Quiz Technical Challenges (Top Hat Interface):

  • Dialogue occurred regarding technical interface latency, unintentional submission overrides, and answer recording issues within the Top Hat platform during preformulation questions.
  • Confirmation of Quiz Item Solutions:
  • BCS Class with high permeability and high solubility is Class I.
  • The appropriate first-class salt counterion for a weak base is chloride ($Cl^-$).
  • Acceptable preformulation criteria require aqueous solubility strictly $> 10\,mg\,cm^{-3}$, $\log(P)$ between $1$ and $3$, and intrinsic dissolution rate strictly $> 1\,mg\,cm^{-2}\,min^{-1}$.
  • Trituration increases effective surface area ($A$), which increases the dissolution rate ($\frac{dM}{dt}$).
  • Substituting a salt for a free base increases boundary layer solubility ($C_s$), which increases $\frac{dM}{dt}$.
  • The assertion that total solubility equals intrinsic solubility at pH values at least two units below the $pK_a$ for a weak acid ($pH \le pK_a - 2$) is True.